share_log

Jazz Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Smith Mark Douglas

Jazz Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Smith Mark Douglas

爵士制药 | 4:持股变动声明-董事 Smith Mark Douglas
美股SEC公告 ·  08/06 18:43
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息